^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    liposomal gemcitabine (FF-10832)

    i
    Other names: FF-10832, F832
    Associations

    News

    Trials
    Company:
    Fujifilm Holdings
    Drug class:
    DNA polymerase inhibitor
    Related drugs:
    Associations

    News

    Trials
    4ms
    KEYNOTE-B57: A Study to Evaluate Safety, Efficacy of FF-10832 in Combination With Pembrolizumab in Solid Tumors (clinicaltrials.gov)
    P2, N=120, Recruiting, Fujifilm Pharmaceuticals U.S.A., Inc. | N=10 --> 120
    Enrollment change • Combination therapy • Metastases
    |
    Keytruda (pembrolizumab) • liposomal gemcitabine (FF-10832)
    5ms
    KEYNOTE-B57: A Study to Evaluate Safety, Efficacy of FF-10832 in Combination With Pembrolizumab in Solid Tumors (clinicaltrials.gov)
    P2, N=10, Recruiting, Fujifilm Pharmaceuticals U.S.A., Inc. | Phase classification: P2a --> P2
    Phase classification • Combination therapy • Metastases
    |
    Keytruda (pembrolizumab) • liposomal gemcitabine (FF-10832)